Evidence map›Paper›PMID 40327122›Full record

ArticleWorld journal of urology2025

A new tool to predict mortality in Fournier's Gangrene: Controlling Nutritional Status (CONUT) score.

Ali Ayten, Mucahit Gelmis, Abdullah Harun Kınık, Deniz Noyan Ozlu, Mustafa Gokhan Kose

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ali AytenDepartment of Urology, Gaziosmanpasa Training and Research Hospital, Istanbul, Turkey. ali.15ayten@gmail.com.ORCID http://orcid.org/0000-0001-8441-1293
Mucahit GelmisDepartment of Urology, Gaziosmanpasa Training and Research Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-8061-6950
Abdullah Harun KınıkDepartment of Urology, Gaziosmanpasa Training and Research Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0001-8121-1480
Deniz Noyan OzluDepartment of Urology, Bitlis State Hospital, Bitlis, Turkey.ORCID http://orcid.org/0000-0003-2435-5482
Mustafa Gokhan KoseDepartment of Urology, Gaziosmanpasa Training and Research Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-2491-0178

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of our study was to demonstrate the role of The Controlling Nutritional Status (CONUT) score in predicting mortality after Fournier's Gangrene (FG) debridement by comparing it with other scoring systems.

methodsData of 193 patients who underwent debridement for FG between January 2013 and December 2024 were retrospectively analyzed. Survivor 156 patients (Group S) and 37 non-survivor patients (Group NS) were divided into two groups. Four scoring systems commonly used to predict mortality in FG and the CONUT score were compared by regression analyses. Cut-off values were determined for each scoring system and ROC curves were constructed.

resultsMortality rate was 19.2%. Total CONUT and other scoring systems were higher in Group NS (p < 0.001). In multivariate analyses, an increase in Total CONUT score predicted mortality (OR = 99.26; 95% CI 8.19-120.30: p < 0.001). The sensitivity, specificity, PPV, NPV and AUC values at the CONUT score ≥ 2.5 cut-off were 86%, 87%, 87%, 87%, 96% and 0.935 (95% CI: 0.88-0.98; p < 0.001), respectively.

conclusionThe CONUT score predicts mortality in FG with high sensitivity and specificity. It is also easy and practical to calculate.

Indexed as

Fournier GangreneNutritional StatusAdultAgedDebridementFemaleHumansMaleMiddle AgedPredictive Value of TestsRetrospective StudiesCONUT scoreFournier gangreneMortalityScoring systems

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.